%0 Journal Article
%T Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
%J -
%D 2019
%R https://doi.org/10.1038/s41391-019-0145-2
%X The fibroblast growth factor receptor (FGFR) signaling pathway is activated in multiple tumor types through gene amplifications, single base substitutions, or gene fusions. Multiple small molecule kinase inhibitors targeting FGFR are currently being evaluated in clinical trials for patients with FGFR chromosomal translocations. Patients with novel gene fusions involving FGFR may represent candidates for kinase inhibitors
%U https://www.nature.com/articles/s41391-019-0145-2